Comparison of Clinical Results of Two Cementless Femoral Stem
NCT ID: NCT04501185
Last Updated: 2023-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2020-06-01
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultra-Short Anatomic and Conventional Cementless Stems Cementless Stems in Patients Younger Than Fifty-Five Years Old
NCT02338596
Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem
NCT01614028
Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty
NCT02247791
The Relationship Between Operative and Radiologic Stem Version
NCT02552173
Anatomical Femoral Stem in Total Hip Arthroplasty
NCT04243980
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To address this challenge, the study focuses on optimizing femoral stem fixation within the proximal femur in two specific stem designs: the UTS and the UTF reduced stem. These stems are strategically designed to enhance load transfer while minimizing stress shielding effects.
A total of 60 patients who are undergoing total hip arthroplasty at Linkou Chang Gung Memorial Hospital will be recruited, including 30 patients in the "UTS" group and 30 patients in the "UTF-reduced" group.The clinical assessments including Success Rate of prosthesis, Numerical Rating Scale (NRS) for pain, Harris Hip Score (HHS), Medical Outcome Study Short Form-36 (SF-36) and : Dual-energy X-ray absorptiometry (DEXA) scanning for bone mineral density monitoring.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
UTS Stem
The subjects who received UTS Stem in total hip arthroplasty.
total hip arthroplasty
The indication for total hip arthroplasty is mainly osteoarthritis.
UTF-reduced Stem
The subjects who received UTF-reduced Stem in total hip arthroplasty.
total hip arthroplasty
The indication for total hip arthroplasty is mainly osteoarthritis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
total hip arthroplasty
The indication for total hip arthroplasty is mainly osteoarthritis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who have not received total hip arthroplasty in the past
Exclusion Criteria
2. Patients who suffer from mental disorders
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United Orthopedic Corporation
INDUSTRY
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pang-Hsin Hsieh, MD
Role: STUDY_DIRECTOR
Chang Gung Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Joint Reconstruction Division at Chang Gung Memorial Hospital, Linkou
Taoyuan, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202000226A3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.